- Report
- March 2024
- 198 Pages
Global
From €3257EUR$3,374USD£2,794GBP
€3619EUR$3,749USD£3,104GBP
- Report
- September 2023
- 180 Pages
Global
From €5743EUR$5,950USD£4,926GBP
- Report
- November 2022
- 132 Pages
Global
From €917EUR$950USD£787GBP
The Hypotensive market within the context of Cardiovascular Drugs is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat hypertension, or high blood pressure. These drugs are used to reduce the risk of stroke, heart attack, and other cardiovascular diseases. Commonly prescribed hypotensive drugs include ACE inhibitors, angiotensin receptor blockers, calcium channel blockers, and diuretics. These drugs are typically prescribed in combination with lifestyle changes such as diet and exercise.
The Hypotensive market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, Novartis, Merck, Sanofi, and GlaxoSmithKline. Show Less Read more